Signal active
Bio
Christy L. Shaffer is a General Partner at Hatteras Venture Partners and was a President and CEO at Inspire Pharmaceuticals. She attended The University of Tennessee Health Science Center.
Location
Raleigh, North Carolina, United States, North America
Social
Primary Organization
2000
113
40
25
11-50
Financial Services, Venture Capital, Medical
Jobs history
16
Aer Therapeutics
Board of Directors
2023 - Current
Trefoil Therapeutics
Board of Directors
2021 - Current
CED
Steering Committee Member (LIFE SCIENCE CONFERENCE, 2015 and 2016)
2014 - Current
The Chordoma Foundation
Member Board Of Directors
2016 - Current
Morehead Planetarium and Science Center
Chair of Advisory Board; Member of Steering Committee for Capital Campaign
2008 - Current
Clearside Biomedical
Board Member
2012 - Current
Hatteras Venture Partners
Managing Director of Hatteras Discovery and General Partner (as of August, 2015)
2011 - Invalid date
CED
Board Member
2016 - Current
Artizan Biosciences
Chair Of The Board Of Directors
2016 - Current
North Carolina School of Science & Mathematics
Foundation board member (former Chair)
2009 - Current
Hatteras Venture Partners
General Partner
2016 - Current
GrayBug
Chair of the Board, member of the Audit and Corporate Governance/Nominating Committees
2015 - Current
Burroughs Wellcome
Member of the Regulatory Initiative advisory board
2016 - Current
RTI International
Member of the Board of Governors, Chair of URCC Committee, Compensation and Finance Committees
2018 - Current
Inspire Pharmaceuticals
President ,CEO , Board Member & Consultant
1995 - 2010
Artizan Biosciences
Board Member
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Christy L. Shaffer is the General Partner at Hatteras Venture Partners, based in United States, North America. With a background in Financial Services, Christy L. Shaffer has a rich history of leadership and innovation. Christy L. Shaffer studied Ph.D Pharmacology @ University of Tennessee Health Science Center. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
2
0
Personal investment
2
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Oct 15, 2010 | EvoApp | Angel Round - EvoApp | 500.0K |
Jan 31, 2011 | EvoApp | Series A - EvoApp | 1.5M |
Partner investment
7
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
May 11, 2016 | G1 Therapeutics | Series C - G1 Therapeutics | Hatteras Venture Partners | 47.0M |
Aug 20, 2019 | GrayBug | Series C - GrayBug | Hatteras Venture Partners | 80.0M |
Dec 01, 2021 | Trefoil Therapeutics | Series A - Trefoil Therapeutics | Hatteras Venture Partners | 28.0M |
Apr 13, 2023 | Aer Therapeutics | Series A - Aer Therapeutics | Hatteras Venture Partners | 36.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.